A multicenter, randomized, double-blind, placebo-controlled phase 2 trial of retosiban, a selective oxytocin receptor antagonist, for the management of preterm labor

The requested reference [215bb7bb16a77aa7ca23ac510a883967765057de] no longer exists in our database. It has been replaced by the current reference: [f571f57e1967080c8a1870d8405d5f940113c580]

Authors
Category Primary study
JournalAMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
Year 2013
This article has no abstract
Epistemonikos ID: 6dbfc1c7e1d5a65dc2b47af3f1868d9b7414a039
First added on: Feb 05, 2025